EUVIMEDEUVIMED entdecken
Crossref

Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using 18F-FDG PET/CT Radiomics

Jianyi Qiao, Bitian Liu, Jun Xin, Siang Shen, Han Ma, Shen Pan

Academic Radiology · 2024

DOI: 10.1016/j.acra.2024.06.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Radiology, 2024. Verfasst von Jianyi Qiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms, Fluorodeoxyglucose F18, Radiopharmaceuticals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE AND OBJECTIVES: This study aims to predict intermediate to high-risk prostate cancer (PCa) prognosis based on 18-fluoro-2-deoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) radiomics. Additionally, subgroup analysis will be performed on the androgen deprivation therapy (ADT) group and the metastatic PCa group. MATERIALS AND METHODS: In the retrospective analysis of 104 intermediate to high-risk PCa patients who underwent 18F-FDG PET/CT prior to treatment. The data set was divided into a training set (n = 72) and a testing set (n = 32). Two different PET/CT models were constructed using multivariate logistic regression with cross-validation: radiomics model A and an alternative ensemble learning-based model B. The superior model was then selected to develop a radiomics nomogram. Separate models were also developed for the ADT and metastatic PCa subgroups. RESULTS: Model A, which integrates eight radiomics features showed excellent performance with an area under curve (AUC) of 0.844 in the training set and 0.804 in the testing set. The radiomics nomogram incorporating the radiomics score (radscore) from model A and the tumor-to-liver ratio (TLR) showed good prognostic accuracy in the testing set with an AUC of 0.827. In the subgroup analyses for endocrine therapy and metastatic cancer, the PET/CT radiomics model showed AUCs of 0.845 and 0.807 respectively, suggesting its potential effectiveness. CONCLUSION: The study establishes the utility of the 18F-FDG PET/CT radiomics nomogram in predicting the prognosis of intermediate to high-risk PCa patients, indicating its potential for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsFluorodeoxyglucose F18RadiopharmaceuticalsAndrogen AntagonistsHumansMalePrognosisRetrospective StudiesAgedMiddle AgedNomogramsTreatment OutcomeRadiomics

Stichwörter der Autor:innen

(18)F-FDG PET/CTAndrogen Deprivation TherapyPrognosisProstate CancerRadiomics

Substanzen

Fluorodeoxyglucose F18RadiopharmaceuticalsAndrogen Antagonists

Autor:innen und Institutionen

  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Urology, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China; Department of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Nuclear Medicine, People's Hospital of Liaoning Province, Shenyang, China.
  • Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China; Department of Nuclear Medicine, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: panshencmu@1…

Zitieren

APA

Qiao, J., Liu, B., Xin, J., Shen, S., Ma, H., & Pan, S. (2024). Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using 18F-FDG PET/CT Radiomics. Academic Radiology. https://doi.org/10.1016/j.acra.2024.06.034

Vancouver

Qiao J, Liu B, Xin J, Shen S, Ma H, Pan S. Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using 18F-FDG PET/CT Radiomics. Academic Radiology. 2024. doi:10.1016/j.acra.2024.06.034

BibTeX
@article{Qiao2024,
  author = {Qiao, Jianyi and Liu, Bitian and Xin, Jun and Shen, Siang and Ma, Han and Pan, Shen},
  title = {Prediction of Prognosis and Response to Androgen Deprivation Therapy in Intermediate to High-Risk Prostate Cancer Using 18F-FDG PET/CT Radiomics},
  journal = {Academic Radiology},
  year = {2024},
  doi = {10.1016/j.acra.2024.06.034}
}
Kostenlos starten →